Trial Profile
Single-dose, Open-label, Randomized, 2-way Crossover Pivotal Bioequivalence Study of 2x5 mg Tablets Rivaroxaban Versus 1x10 mg Tablet Rivaroxaban Under Fasted Condition in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2014
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism
- Focus Pharmacokinetics
- Sponsors Bayer
- 21 Sep 2011 New trial record